Coronavirus Live
Coronavirus: A timeline of how the deadly COVID-19 outbreak is evolving
Live timeline of how the Coronavirus outbreak has evolved and the impacts on the pharmaceutical industry and beyond.
Focus:
-
![IRT: A competitive advantage to accelerate clinical trials during a global pandemic and beyond]()
IRT: A competitive advantage to accelerate clinical trials during a global pandemic and beyond
-
![No time to waste: repurposing drugs to tackle Covid-19]()
No time to waste: repurposing drugs to tackle Covid-19
-
![Pharma Technology Focus: Pandemic pricing]()
Pharma Technology Focus: Pandemic pricing
-
![Generics and the Covid-19 pandemic: Q&A with Accord’s Dr Anthony Grosso]()
Generics and the Covid-19 pandemic: Q&A with Accord’s Dr Anthony Grosso
-
![Veeva R&D summit 2020: putting patients at the centre of clinical research]()
Veeva R&D summit 2020: putting patients at the centre of clinical research
-
![PTC acquires Censa: diversifying into metabolic disease]()
PTC acquires Censa: diversifying into metabolic disease
Coronavirus Live
- GlobalData Epidemiologist Report: More than 372,000 Covid-19 deaths globally – cases rise in Brazil and Qatar – risk of second wave in US
- Eli Lilly launches world’s first clinical trial of antibody-based drug for Covid-19
- Gilead’s remdesivir a candidate for US government stockpiling or bulk buying in private sector
Expert commentary & analysis from GlobalData
Chemokine inhibitors in the bullous pemphigoid pipeline may be the safest treatment for refractory patients
Gilead’s remdesivir a candidate for US government stockpiling or bulk buying in private sector
Finding a cure for HIV with ViiV Healthcare and UNC-Chapel Hill
Coronavirus company news summary – Moderna starts doses participants in Phase II Covid-19 vaccine trial – Gilead’s remdesivir receives conditional approval in Taiwan
Most Read
Company releases
High Containment Sterisplit
SteriSplit is a high-containment butterfly valve, which has been developed to safely transfer powders for sterile or potentially toxic products.
Rotocrusher
Rotovalve Plus
Rotovalve Plus has been developed to assist with the feeding and volumetric dosing of bulk solid products.
Rotodoser
Rotovalve Light
Rotovalve Light is a rotary valve for use within the pharmaceutical field.
Company whitepapers
Sterivalves: Process Advantage
SteriValvesElemental Impurity Analysis in Pharmaceuticals and Implementation of ICH Q3D
Butterworth LaboratoriesA Cold Chain Process Validation Guide
Modality SolutionsPharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction
Malvern PanalyticalWorld Federation of Hemophilia Minimises Temperature Deviations on Deliveries of Lifesaving Drugs Using PalletQuilt® Covers
QProducts & Services®Specialised Translation Services for the Life Sciences Sector
NN TranslationsAnalyser for Microtiter Plate-Based Bioassays
Cellular Technology Limited (CTL)Company A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Takara Bio’s Center for Gene and Cell Therapy Processing II, Shiga
Takara Bio opened its new facility, the Center for Gene and Cell Therapy Processing II (CGCPII), in Shiga, Japan.
GlaxoSmithKline’s (GSK) Pharmaceutical Tablet Manufacturing Factory, Karnataka
IDT’s New Manufacturing Facility, North Carolina
Evonik’s New Biomaterials Manufacturing Facility, Birmingham, Alabama
BioCentriq Cell and Gene Therapy Manufacturing Centre, Newark, USA
Clinical Trials
India’s CSIR proposes testing of sepsis drug as Covid-19 vaccine
The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a vaccine for Covid-19.
CSL Behring Australia joins race for Covid-19 therapy development
Trial shows Covid-19 patients recover with Gilead’s remdesivir
Gilead says leaked Covid-19 trial data of remdesivir inconclusive
NIH panel warns against use of hydroxychloroquine to treat Covid-19
Design
Almirall signs deal for Iktos’ AI technology in drug design
Spanish pharmaceutical firm Almirall has agreed with Iktos to leverage the latter’s generative modelling artificial intelligence (AI) technology to design novel drugs.
USPTO reverses decision regarding interfering CRISPR patents
Dassault to enhance clinical tech with $5.8bn Medidata acquisition
ProAmpac updates child-resistant pouch product line
Drug Development
Celltrion’s Covid-19 antibody therapy reduces viral load in animal tests
South Korea-based Celltrion Group has reported positive results from the preclinical tests of its Covid-19 antibody treatment, which led to a 100-fold decrease in the...
Chimeron Bio and NCBID to develop Covid-19 vaccine
Gilead and Arcus Biosciences partner to develop cancer drugs
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19
Merck joins race to develop Covid-19 vaccines and drugs
Market Data
UK grants early access to Gilead’s remdesivir for Covid-19
The UK Government has announced that some adults and adolescents hospitalised with Covid-19 on the National Health Service (NHS) will have access to Gilead Sciences'...
UEA research calls for changes to pharmaceutical deals system
Sobi releases new haemophilia treatment report
EMA advises malaria drugs use for trials only; FDA records shortage
FDA calls for removal of all ranitidine products from market
Technology
Predictive Oncology joins race to develop Covid-19 vaccine
Predictive Oncology has joined the race to develop a Covid-19 vaccine with the acquisition of Soluble Therapeutics, followed by collaboration and licensing of a new...
Novartis expands ophthalmology pipeline with Amblyotech acquisition
Insilico and Boehringer to use AI for drug targets discovery
Predictive to launch AI drug discovery platform for Covid-19
Iktos and SRI to use AI for Covid-19 drug development
Your recommended content
Why we believe workplace health and wellness is important
Your recommended content
Reinventing construction: Innovating the delivery of construction projects
Download a free 10 page preview of our Mergers & Acquisitions in TMT – Thematic Research 2019 Report
Go Top